Accessibility Menu
 
Immutep logo

Immutep

(ASX) IMM

Current Price$0.06
Market Cap$86.95M
Since IPO (1992)-98%
5 Year-87%
1 Year-78%
1 Month+26%

Immutep Financials at a Glance

Market Cap

$86.95M

Revenue (TTM)

$10.86M

Net Income (TTM)

$127.78M

EPS (TTM)

$-0.06

P/E Ratio

-1.03

Dividend

$0.00

Beta (Volatility)

0.05 (Low)

Price

$0.06

Volume

13,595,293

Open

$0.06

Previous Close

$0.06

Daily Range

$0.06 - $0.06

52-Week Range

$0.03 - $0.47

IMM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Immutep

Industry

Biotechnology

CEO

Marc Voigt, MBA

Headquarters

Sydney, NSW 2000, AU

IMM Financials

Key Financial Metrics (TTM)

Gross Margin

-5%

Operating Margin

-21%

Net Income Margin

-14%

Return on Equity

-62%

Return on Capital

-1%

Return on Assets

-57%

Earnings Yield

-97.09%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$86.95M

Shares Outstanding

1.47B

Volume

13.60M

Avg. Volume

38.63M

Financials (TTM)

Gross Profit

$56.37M

Operating Income

$126.42M

EBITDA

$62.88M

Operating Cash Flow

$62.05M

Capital Expenditure

$45.77K

Free Cash Flow

$62.10M

Cash & ST Invst.

$129.69M

Total Debt

$1.63M

Immutep Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$4.08M

+93.3%

Gross Profit

$2.95M

+116.1%

Gross Margin

72.34%

N/A

Market Cap

$86.95M

N/A

Market Cap/Employee

$4.58M

N/A

Employees

19

N/A

Net Income

$44.86M

-111.3%

EBITDA

$46.84M

-111.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$96.97M

-5.0%

Accounts Receivable

$37.52M

+510.4%

Inventory

$0.00

N/A

Long Term Debt

$1.90M

+35.2%

Short Term Debt

$260.00K

-38.1%

Return on Assets

-57.01%

N/A

Return on Invested Capital

-1.22%

N/A

Free Cash Flow

$28.74M

-414.1%

Operating Cash Flow

$28.65M

-412.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PAR.AXParadigm Biopharmaceuticals Limited
$0.16-5.88%
BOT.AXBotanix Pharmaceuticals Limited
$0.03-3.57%
DXB.AXDimerix Limited
$0.21-6.52%
OCC.AXOrthocell Limited
$0.90+0.56%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOFISoFi Technologies
$16.10+0.04%
AAPLApple
$271.35+0.00%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.63+0.10%
MARAMara Holdings
$11.99+0.12%

Questions About IMM

What is the current price of Immutep?

Immutep is trading at A$0.06 per share.

What is the 52-week range for Immutep?

Over the past 52 weeks, Immutep has traded between A$0.03 and A$0.47.

How much debt does Immutep have?

As of the most recent reporting period, Immutep reported total debt of $1.63M.

How much cash does Immutep have on hand?

Immutep reported $67.41M in cash and cash equivalents in its most recent financial results.

What is Immutep’s dividend yield?

Immutep does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.